What Happened?
Cambridge, MA-based Verve-Therapeutics Appointed Sekar Kathiresan as Chief Executive Officer
About the Company
Verve Therapeutics is a biotechnology company focused on discovering and developing therapies that safely edit the genomes of adults to confer lifelong protection against coronary artery disease, the most common type of heart disease and the leading cause of death worldwide. Headquartered in Cambridge, Mass., with a research facility in Philadelphia.
About the Person
Sekar Kathiresan is Chief Executive Officer at Verve Therapeutics. Previously, Sekar held various senior HR leadership roles in the industry.
Info Source
News
Short Profile